Search Results
Results found for "Evaxion Biotech"
- Are You Guessing or Forecasting? Master GPCR Pharmacologic Models Before It’s Too Late
🔹 Spot the opportunity → Why Catalio is betting big when others pull back Amid biotech slowdowns
- New Podcast, Sweet Structures & $2.2B GPCR Moves
Explore this week’s research, tools, and biotech insights in one place.
- Subscribe to Dr. GPCR Newsletter Today!
Did you know that each month we collect the most recent #GPCR publications and the newest Biotech/Pharma
- Embark on a GPCR Adventure: Your Weekly Research Expedition! | Oct 21-27, 2024
School of Medicine to Receive $3-Million Award from ARPA-H’s Sprint for Women’s Health Nxera Pharma Wins Biotech Year and Financing Deal of the Year at the Citeline Japan Awards 2024 GPCR therapies: Eight promising biotechs
- 📰 GPCR Weekly News, March 20 to 26, 2023
Industry News Domain Therapeutics was one of the 4 Biotech Trophy nominees at 2023 HealthTech awards. The delisting dilemma: Why do so many biotechs face being kicked off the Nasdaq?. (April 20 - 21, 2023) Swiss Biotech Day (April 24 - 25, 2023) SLAS Europe 2023 Conference and Exhibition
- Your GPCR Program Decisions Depend on Good Data Interpretation
productive lab—it accelerated outcomes and laid the cultural foundation for the next generation of biotech insights from major conferences, emerging research, and expert commentary Whether you’re a pharmacologist, biotech
- Signals in Motion: Pain, Metabolism & Terry’s Corner
Explore this week’s research, tools, and biotech insights in one place.
- New Tools, Smart Signals, and The Kenakin Brief
Explore this week’s research, tools, and biotech insights in one place. The insights are ready.
- Why Kinetics Matter More Than Kd in GPCR Drug Discovery
insights from major conferences, emerging research, and expert commentary Whether you’re a pharmacologist, biotech GPCR scientists, translational pharmacologists, biotech drug discovery teams, and decision-makers who
- X4 slashes pipeline, lays off staff just three weeks after netting a $55M PIPE
The Boston biotech revealed Wednesday afternoon that it would downsize its research to focus on its lead
- Dr. GPCR and Celtarys Research Join Forces to Expand Access to Innovative GPCR Tools
About Celtarys Research Celtarys Research is a biotech company based in Spain that specializes in the
- 📰 GPCR Weekly News, April 17 to 23, 2023
pathway of opioid drugs into cellular structures Inversago Pharma will present at BBHIC 2023 Orion Biotechnology attended the Swiss Biotech Day Addex Therapeutics attended the Swiss Biotech Day Sosei Heptares presented
- Verily links up with Sosei Heptares for GPCR drug discovery
January 2022 "G-protein-coupled receptors’ star has been on the rise in biotech in recent years as researchers
- Septerna emerges with $100M to spark 'second golden age' of prolific drug target GPCR with ...
fruitful research space has led to more than 700 approved drugs over previous decades—but the two-year-old biotech
- Pharmacology at Your Fingertips: Terry’s Corner Launches
Plus: must-read chemokine and PTH1R papers, and new momentum across biotech—from Superluminal to Neurocrine
- Third Rock pushes newest fund over $1B line as it marks 15 years in venture capital
That money has gone to some 60 biotechs, much of it as early funding."
- Inversago Pharma Announces Dosing of First Participant with Metabolic Syndrome in Phase 1B ...
(“Inversago”), a clinical stage biotech company with a unique portfolio of CB1 inverse agonists, announced
- 📰 GPCR Weekly News, January 16 to 22, 2023
Joanne Waldstreicher to its Board of Directors GPCR Therapeutics launches multiple myeloma trial Salipro Biotech organized by LINK-J Jounce takes the cash under amended deal with Gilead on anti-CCR8 antibody InterAx Biotech
- 📰 GPCR Weekly News, September 4 to 10, 2023
Our partner, Domain Therapeutics, will attend the SACHS 23rd annual biotech event in Europe. Dr. Therapeutics CEO Pascal Neuville to Discuss Game-Changing GPCR-Targeting Immunotherapies at Sachs Associates' Biotech
- 📰 GPCR Weekly News, January 1 to 7, 2024
Inês Pinheiro and Oliver Hartley from the Orion Biotechnology team on their recent study on Arylsulfatases Enter Agreement for Rhythm to Acquire Global Rights to Oral MC4R Agonist LB54640 Addex to Present at Biotech Conference Isomorphic Labs Announces Strategic Multi-Target Research Collaboration With Novartis Salipro Biotech
- 📰 GPCR Weekly News, February 6 to 12, 2023
Industry News Biotech startup Structure pulls off rare IPO, raising $161M 3-drug combo leads to 'unprecedented Pharmaceuticals Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) arcoscreen is one of the 13 biotech
- Accelerating GPCR Drug Discovery
I've seen this pattern unfold across biotech, academia, and nonprofits.
- 📰 GPCR Weekly News, May 8 to 14, 2023
Industry News InterAx Biotech to Apply its Leading AI and Cell Signalling Technology to Support Target Validation for a Sosei Heptares GPCR Discovery Program Salipro Biotech and DyNAbind Announce Milestone
- Orthosteric vs Allosteric Interactions— and the pHSense Shift in Internalization
with your topic suggestions 🆕 Weekly new releases to stay ahead of the science 🧠 Content built for biotech GPCR scientists, translational pharmacologists, biotech discovery teams, and decision-makers who need
- Allosteric Binding Demystified: Smarter GPCR Drug Discovery
GPCR scientists, translational pharmacologists, biotech discovery teams, and decision-makers who need
- 🎄 Have Yourself a Merry Little GPCRmas! ❄ Dec 9 - 15, 2024
unanswered questions about blockbuster weight-loss drugs Transforming Drug Discovery: Insights from Viva Biotech's
- 📰 GPCR Weekly News, March 27 to April 4, 2023
Therapeutics Reports Fourth Quarter and Full Year 2022 Financial Results and Recent Highlights Salipro Biotech (April 20 - 21, 2023) Swiss Biotech Day (April 24 - 25, 2023) SLAS Europe 2023 Conference and Exhibition
- Oxford Professor Of Chemistry And Founder Of Therapeutic Company Wins Two International Awards
prestigious international award – exemplified by the fact that other winners this year are the co-founders of BioNTech
- Assay Volume Control: Your GPCR Drug Discovery Power Lever
curriculum with your topic suggestions Weekly new releases to stay ahead of the science Content built for biotech
- 📰 GPCR Weekly News, October 9 to 15, 2023
Chris Cargill Wins Executive of the Year at the Citeline Pharma Intelligence Awards Japan 2023 Salipro Biotech















